Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
Biochemical Pharmacology|December 2, 2006
Gene expression and regulation of drug transporters in the intestine and kidneyTomohiro Terada, Ken-ichi InuiPharmacology & Therapeutics|June 9, 2006
An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patientsSatohiro Masuda, Ken-ichi InuiBiochemical Pharmacology|December 15, 2010
Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agentsAtsushi Yonezawa, Ken-Ichi InuiCurrent Drug Metabolism|February 18, 2004
Peptide transporters: structure, function, regulation and application for drug deliveryTomohiro Terada, Ken-ichi InuiMolecular Aspects of Medicine|March 20, 2013
Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-KHideyuki Motohashi, Ken-ichi InuiBiochemical Pharmacology|February 12, 2008
Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A)Tomohiro Terada, Ken-ichi InuiBritish Journal of Pharmacology|April 5, 2011
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomicsAtsushi Yonezawa, Ken-ichi InuiMolecular Aspects of Medicine|March 20, 2013
Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52Atsushi Yonezawa, Ken-ichi InuiDrug Metabolism and Pharmacokinetics|December 25, 2004
Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulationToshiya Katsura, Ken-Ichi InuiThe AAPS Journal|February 26, 2013
Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidneyHideyuki Motohashi, Ken-ichi InuiPageof 19